Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Base estimates and calculations
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 MEA
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Biopsy needle market industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Biopsy Needle Industry Insights
3.1 Industry segmentation
3.2 Industry ecosystem analysis
3.2.1 Vendor Matrix
3.2.2 Distribution channel analysis
3.2.3 Profit margin trends
3.3 Raw material analysis
3.2.1 Nanomaterials
3.2.2 Polymers
3.2.3 Semiconductors
3.2.4 Others
3.3 Pricing analysis 2018 – 2032
3.3.1 Pricing analysis, by region
3.3.1.1 North America
3.3.1.2 Europe
3.3.1.3 Asia Pacific
3.3.1.4 Latin America
3.3.1.5 Middle East & Africa
3.4 Cost structure analysis
3.4.1 Component/material costs
3.4.2 Manufacturing & labour costs
3.4.3 Utilities
3.4.4 Maintenance cost
3.4.5 Finance cost
3.4.6 Administration cost
3.4.7 Others
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Rising incidence of cancer across the globe
3.5.1.2 Technological advancements in biopsy needles
3.5.1.3 Favorable reimbursement scenario
3.5.1.4 Increasing awareness regarding breast cancer
3.5.2 Industry pitfalls & challenges
3.5.2.1 Risk of complications after biopsy
3.5.2.2 Dearth of skilled healthcare professionals
3.6 Growth potential analysis
3.6.1 By product
3.6.2 By application
3.6.3 By end-use
3.7 COVID- 19 impact analysis
3.8 Regulatory landscape
3.8.1 U.S.
3.8.2 Europe
3.9 Application landscape
3.10 Industry eco-system
3.10.1 Current trends in the industry
3.10.2 Start-up scenario
3.11 Porter's analysis
3.11.1 Bargaining power of suppliers
3.11.2 Bargaining power of buyers
3.11.3 Threat of new entrants
3.11.4 Threat of substitutes
3.11.5 Industry rivalry
3.12 PESTEL analysis
3.12.1 Political
3.12.2 Economical
3.12.3 Social
3.12.4 Technological
3.12.5 Environmental
3.12.6 Legal
Chapter 4 Competitive landscape
4.1 Introduction
4.2 Company market share, 2021
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix
Chapter 5 Biopsy Needle Market, By Product
5.1 Key product trends
5.2 Needle based biopsy guns
5.2.1 Vacuum-assisted biopsy (VAB) devices
5.2.2 Fine needle aspiration biopsy (FNAB) devices
5.2.3 Core needle biopsy (CNB) devices
5.3 Biopsy needles
5.3.1 Disposable
5.3.2 Reusable
Chapter 6 Biopsy Needle Market, By Application
6.1 Key application trends
6.2 Cancer/tumor
6.2.1 Breast
6.2.2 Lung
6.2.3 Prostate
6.2.4 Colon
6.2.5 Stomach
6.2.6 Liver
6.2.7 Rectum
6.2.8 Cervix uteri
6.2.9 Oesophagus
6.2.10 Pancreas
6.2.11 Leukaemia
6.2.12 Other cancer
6.3 Infectious diseases
6.4 Autoimmune disorder
6.5 Others
Chapter 7 Biopsy Needle Market, By End-use
7.1 Key end-use trends
7.2 Hospitals
7.3 Ambulatory surgical center
7.4 Others
Chapter 8 Biopsy Needle Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
Chapter 9 Company Profiles
9.1 Boston Scientific Corporation
9.2 Medtronic plc
9.3 FUJIFILM Holdings Corporation
9.4 Becton, Dickinson and Company (BD)
9.5 Cardinal Health
9.6 Olympus Corporation
9.7 Hologic Inc
9.8 Argon Medical Devices, Inc
9.9 B. Braun Melsungen AG
9.10 Devicor Medical Products, Inc. (Danaher Corporation)
9.11 Cook Group Incorporated
9.12 INRAD Inc
9.13 Stryker Corporation
